Cargando…

Identifying regions for enhanced control of gambiense sleeping sickness in the Democratic Republic of Congo

Gambiense human African trypanosomiasis (sleeping sickness, gHAT) is a disease targeted for elimination of transmission by 2030. While annual new cases are at a historical minimum, the likelihood of achieving the target is unknown. We utilised modelling to study the impacts of four strategies using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Ching-I, Crump, Ronald E., Brown, Paul E., Spencer, Simon E. F., Miaka, Erick Mwamba, Shampa, Chansy, Keeling, Matt J., Rock, Kat S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933483/ https://www.ncbi.nlm.nih.gov/pubmed/35304479 http://dx.doi.org/10.1038/s41467-022-29192-w

Ejemplares similares

Quantifying epidemiological drivers of gambiense human African Trypanosomiasis across the Democratic Republic of Congo
por: Crump, Ronald E., et al.
Publicado: (2021)

Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo
por: Antillon, Marina, et al.
Publicado: (2022)

Cost-effectiveness modelling to optimise active screening strategy for gambiense human African trypanosomiasis in endemic areas of the Democratic Republic of Congo
por: Davis, Christopher N., et al.
Publicado: (2021)

Modelling to infer the role of animals in gambiense human African trypanosomiasis transmission and elimination in the DRC
por: Crump, Ronald E., et al.
Publicado: (2022)

Predicting the impact of COVID-19 interruptions on transmission of gambiense human African trypanosomiasis in two health zones of the Democratic Republic of Congo
por: Aliee, Maryam, et al.
Publicado: (2021)

Screening Strategies for a Sustainable Endpoint for Gambiense Sleeping Sickness
por: Castaño, M Soledad, et al.
Publicado: (2020)

A modelling assessment of short- and medium-term risks of programme interruptions for gambiense human African trypanosomiasis in the DRC
por: Huang, Ching-I, et al.
Publicado: (2023)

Modelling gambiense human African trypanosomiasis infection in villages of the Democratic Republic of Congo using Kolmogorov forward equations
por: Davis, Christopher N., et al.
Publicado: (2021)

Village-scale persistence and elimination of gambiense human African trypanosomiasis
por: Davis, Christopher N., et al.
Publicado: (2019)

Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo
por: Rock, Kat S., et al.
Publicado: (2017)

Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo
por: Rock, Kat S., et al.
Publicado: (2015)

Modelling to Quantify the Likelihood that Local Elimination of Transmission has Occurred Using Routine Gambiense Human African Trypanosomiasis Surveillance Data
por: Davis, Christopher N, et al.
Publicado: (2021)

Assessing Strategies Against Gambiense Sleeping Sickness Through Mathematical Modeling
por: Rock, Kat S, et al.
Publicado: (2018)

The Flipside of Eradicating a Disease; Human African Trypanosomiasis in a Woman in Rural Democratic Republic of Congo: A Case Report
por: Mudji, Junior, et al.
Publicado: (2019)

Melarsoprol Sensitivity Profile of Trypanosoma brucei gambiense Isolates from Cured and Relapsed Sleeping Sickness Patients from the Democratic Republic of the Congo
por: Pyana Pati, Patient, et al.
Publicado: (2014)

Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and risk
por: Lumbala, Crispin, et al.
Publicado: (2015)

Impact of tiny targets on Glossina fuscipes quanzensis, the primary vector of human African trypanosomiasis in the Democratic Republic of the Congo
por: Tirados, Inaki, et al.
Publicado: (2020)

Modelling the impact of fexinidazole use on human African trypanosomiasis (HAT) transmission in the Democratic Republic of the Congo
por: Das, Aatreyee M., et al.
Publicado: (2021)

High Failure Rates of Melarsoprol for Sleeping Sickness, Democratic Republic of Congo
por: Robays, Jo, et al.
Publicado: (2008)

Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo
por: Kuemmerle, Andrea, et al.
Publicado: (2020)

Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study
por: Kuemmerle, Andrea, et al.
Publicado: (2021)

Community empowerment through participation in a tsetse control project in the Democratic Republic of Congo
por: Vander Kelen, Catiane, et al.
Publicado: (2023)

Cost of a new method of active screening for human African trypanosomiasis in the Democratic Republic of the Congo
por: Snijders, Rian, et al.
Publicado: (2020)

Trypanosomiasis Control, Democratic Republic of Congo, 1993–2003
por: Lutumba, Pascal, et al.
Publicado: (2005)

Challenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo
por: Tong, Jacqueline, et al.
Publicado: (2011)

Examination of scenarios introducing rubella vaccine in the Democratic Republic of the Congo
por: Cheng, Alvan, et al.
Publicado: (2021)

Performance of the SD BIOLINE® HAT rapid test in various diagnostic algorithms for gambiense human African trypanosomiasis in the Democratic Republic of the Congo
por: Lumbala, Crispin, et al.
Publicado: (2017)

An Active Follow-up Strategy for Serological Suspects of Human African Trypanosomiasis with Negative Parasitology Set up by a Health Zone Team in the Democratic Republic of Congo
por: Nkieri, Matthieu, et al.
Publicado: (2020)

Costs and Outcomes of Integrated Human African Trypanosomiasis Surveillance System Using Rapid Diagnostic Tests, Democratic Republic of the Congo
por: Snijders, Rian, et al.
Publicado: (2021)

Do Cryptic Reservoirs Threaten Gambiense-Sleeping Sickness Elimination?
por: Büscher, Philippe, et al.
Publicado: (2018)

Feasibility of community-based control of tsetse: A pilot project using Tiny Targets in the Democratic Republic of Congo
por: Vander Kelen, Catiane, et al.
Publicado: (2020)

Modelling to explore the potential impact of asymptomatic human infections on transmission and dynamics of African sleeping sickness
por: Aliee, Maryam, et al.
Publicado: (2021)

‘Where are the dead flies!’: perceptions of local communities towards the deployment of Tiny Targets to control tsetse in the Democratic Republic of the Congo
por: Vander Kelen, Catiane, et al.
Publicado: (2022)

Ocular Pentastomiasis in the Democratic Republic of the Congo
por: Sulyok, Mihály, et al.
Publicado: (2014)

Adult intussusception in the Democratic Republic of Congo
por: Groen, Reinou S., et al.
Publicado: (2011)

The Ebola Resurgence in Democratic Republic of Congo
por: Sah, Ranjit, et al.
Publicado: (2022)

Should I Get Screened for Sleeping Sickness? A Qualitative Study in Kasai Province, Democratic Republic of Congo
por: Mpanya, Alain, et al.
Publicado: (2012)

Changes in childhood vaccination coverage over time in the Democratic Republic of the Congo
por: Alfonso, Vivian H., et al.
Publicado: (2019)

Tetanus seroprotection among children in the Democratic Republic of the Congo, 2013–2014
por: Cheng, Alvan, et al.
Publicado: (2022)

From Health Advice to Taboo: Community Perspectives on the Treatment of Sleeping Sickness in the Democratic Republic of Congo, a Qualitative Study
por: Mpanya, Alain, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c76er94k4sfaa1d469v8dirc90